Median PSA level (>4 ng/ml or ≤4 ng/ml), definite cut-off value, subject (low-risk PCa or patients suspected with PCa), and sample size (≤50 or >50) were included as covariates in a meta-regression analysis (Fig 5). This evidence concerns the gene KLK3 and posterior cortical atrophy.